{
    "title": "AstraZeneca, Ionis eye U.S. approval after positive trial data",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10937307/AstraZeneca-Ionis-eye-U-S-approval-positive-trial-data.html",
    "date": "2022-06-21",
    "keywords": [
        "drug",
        "year",
        "grover",
        "astrazeneca",
        "latestage",
        "disease",
        "market",
        "therapy",
        "diagnosis",
        "transthyretin",
        "condition",
        "deal",
        "attr",
        "london",
        "june",
        "analysis",
        "partner",
        "ionis",
        "trial",
        "drugmaker",
        "tuesday",
        "application",
        "polyneuropathy",
        "nerve",
        "damage",
        "motor",
        "disability",
        "treatment",
        "decade",
        "production",
        "ttr",
        "protein",
        "accumulation",
        "study",
        "eplontersen",
        "use",
        "cardiomyopathy",
        "attrcm",
        "heart",
        "failure",
        "death",
        "worldwide",
        "cambridge",
        "company",
        "front",
        "milestone",
        "handful",
        "field",
        "alnylam",
        "approval",
        "pfizer",
        "pair",
        "vyndaqel",
        "vyndamax",
        "novo",
        "nordisk",
        "prothena",
        "corps",
        "reporting",
        "editing",
        "goodman",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}